# Study to Investigate the Relative Bioavailability of Ibuprofen in Healthy Volunteers

> **NCT02183012** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 36 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Ibuprofen extrudate
- **DRUG:** Ibuprofen lysinate
- **DRUG:** Ibuprofen

## Key facts

- **NCT ID:** NCT02183012
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-08
- **Primary completion:** 2002-10
- **Final completion:** —
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2014-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02183012

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02183012, "Study to Investigate the Relative Bioavailability of Ibuprofen in Healthy Volunteers". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02183012. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*